Comparative in vivo expression of amastigote up regulated Leishmania genes in three different forms of Leishmaniasis

Parasitology International

Volumn 59, Issue 2, 2010, Pages 262-264

  Sharma, Paresh ^a   Gurumurthy, Srividya ^a   Duncan, Robert ^b   Nakhasi, Hira L ^b   Salotra, Poonam ^a  

^a SAFDARJUNG HOSPITAL CAMPUS   (India)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

CL; Gene expression; Leishmania; PKDL; Real time PCR; VL

Indexed keywords

ALPHA TUBULIN; AMASTIGOTE SPECIFIC PROTEIN A2; E1 LIKE UBIQUITIN FOLD MODIFIER ACTIVATING ENZYME; MEMBRANE PROTEIN; MESSENGER RNA; MITOCHONDRIAL MEMBRANE PROTEIN P27; MITOGEN ACTIVATED PROTEIN KINASE; PARASITE ANTIGEN; PROTEIN UBA5; UNCLASSIFIED DRUG;

AMASTIGOTE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LEISHMANIA; POST KALA AZAR DERMAL LEISHMANIASIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SKIN LEISHMANIASIS; UPREGULATION; VISCERAL LEISHMANIASIS;

ANIMALS; HUMANS; INDIA; LEISHMANIA DONOVANI; LEISHMANIA TROPICA; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS; RNA, MESSENGER; SKIN; SPECIES SPECIFICITY; UP-REGULATION;

LEISHMANIA DONOVANI; LEISHMANIA TROPICA; NASO HEXACANTHUS;

EID: 77951623346     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2009.11.003     Document Type: Article

References (16)

1. Murray H.W., Berman J.D., Davies C.R., and Saravia N.G. Advances in leishmaniasis. Lancet 366 (2005) 1561-1577
2. World Health Organization. Control of leishmaniasis. Expert committee. WHO Technical Report series vol. 793 (1990) 27
3. Ramesh V., and Mukherjee A. Post kala-azar dermal leishmaniasis. Int J Dermatol 34 (1995) 85-91
4. Zijlstra E.E., Musa A.M., Khalil E.A., el-Hassan I.M., and el-Hassan A.M. Post kala azar dermal leishmaniasis. Lancet Infect Dis 3 (2003) 87-98
5. Kumar R., Bumb R.A., Ansari N.A., Mehta R.D., and Salotra P. Cutaneous leishmaniasis caused by Leishmania tropica in Bikaner, India: parasite identification and characterization using molecular and immunologic tools. Am J Trop Med Hyg 76 (2007) 896-901
6. Srividya G., Duncan R., Sharma P., Raju B.V., Nakhasi H.L., and Salotra P. Transcriptome analysis during the process of in vitro differentiation of Leishmania donovani using genomic microarrays. Parasitol 134 (2007) 1527-1539
7. Sreenivas G., Singh R., Selvapandiyan A., Negi N.S., Nakhasi H.L., and Salotra P. Arbitrary-primed PCR for genomic fingerprinting and identification of differentially regulated genes in Indian isolates of Leishmania donovani. Exp Parasitol 106 (2004) 110-118
8. Charest H., and Matlashewski G. Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene. Mol Cell Biol 14 (1994) 2975-2984
9. ABI. Relative quantitation of gene expression. User bulletin No.2. ABI prism 7700 Sequence detection system. PE Applied Biosystems (1997)
10. Rochette A., Raymond F., Ubeda J.M., Smith M., Messier N., Boisvert S., et al. Genome-wide gene expression profiling analysis of Leishmania major and Leishmania infantum developmental stages reveals substantial differences between the two species. BMC Genomics 9 (2008) 255-270
11. McMahon-Pratt D., and Alexander J. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?. Immunol Rev 201 (2004) 206-224
12. Salotra P., Duncan R., Singh R., Raju B.V., Sreenivas G., and Nakhasi H.L. Up regulation of surface proteins in Leishmania donovani isolated from patients of post kala-azar dermal leishmaniasis. Microbes Infect (2006) 1-8
13. Komatsu M., Chiba T., Tatsumi K., Iemura S., Tanida I., Okazaki N., et al. A novel protein-conjugating system for Ufm1, a ubiquitin-fold modifier. EMBO J 23 (2004) 1977-1986
14. Zhang W.W., Mendez S., Ghosh A., Myler P., Ivens A., Clos J., et al. Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection. J Biol Chem 37 (2003) 35508-35515
15. Ghedin E., Zhang W., Charest H., Sundar S., Kenny R.T., and Matlashewski G. Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis. Clin Diagn Lab Immun (1997) 530-535
16. Zhang W.W., and Matlashewski G. Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection. Mol Microbiol 39 (2001) 935-948